Ignite Creation Date:
2025-12-25 @ 4:45 AM
Ignite Modification Date:
2026-03-01 @ 5:20 PM
Study NCT ID:
NCT02607618
Status:
COMPLETED
Last Update Posted:
2018-08-07
First Post:
2015-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2
Sponsor:
Motif Bio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2017-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-13
First Submit QC Date:
None
Study First Post Date:
2015-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-14
Results First Submit QC Date:
None
Results First Post Date:
2018-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-10
Last Update Post Date:
2018-08-07
Last Update Post Date Type:
ACTUAL